StockData
Cumberland Pharmaceuticals Inc logo

Cumberland Pharmaceuticals Inc (CPIX) income statement

CPIXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 5/3086% above fair value
$6.57+0.77 (+13.28%)

Close on Nov 18, 2026Market cap $98.44MP/E –Yield –

Cumberland Pharmaceuticals Inc financial ratios

See a number that looks wrong?